CD248 and pulmonary arterial hypertension: The following article from Clinical and Translational Medicine, "CD248 as a novel therapeutic target in pulmonary arterial hypertension" by Tao Xu, Lei Shao, Aimei Wang, Rui Liang, Yuhan Lin, GuanWang, Yan Zhao, Jing Hu, and Shuangyue Liu,<sup>1</sup> published online on September 17, 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor-in-Chief, Xiangdong Wang and John Wiley & Sons, Ltd. The retraction has been agreed due to duplicate use of figures and data in the article.